Dabigatran Etexilate and Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))
Determining the interaction of Dabigatran Etexilate and Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq)) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabigatran
Brand name: Pradaxa
Synonyms: Dabigatran
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabigatran Etexilate-Nuwiq recombinant
- Dabigatran Etexilate-NuZole
- Dabigatran Etexilate-Nuzyra
- Dabigatran Etexilate-Nuzyra (Omadacycline Injection)
- Dabigatran Etexilate-Nuzyra (Omadacycline Tablets)
- Dabigatran Etexilate-Nuzyra Intravenous
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Dabigatran Etexilate Mesylate
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Dabrafenib
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Dabrafenib Mesylate
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Dacarbazine
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Dacarbazine Intravenous, Injection
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Daclatasvir